1. HBW Insight
  2. >>Ingredients & Safety

AI Beauty Solutions Firm Perfect Corp. Going Public Through SPAC; Cosmetics News In Brief

Perfect Corp. will combine with Hong Kong-based special purpose acquisition company Provident Acquisition Corp. and list on the Nasdaq Stock Exchange in a transaction expected to close in the 2022 third quarter. Sequential Skin launches microbiome in vivo testing to companies assessing product or ingredient impacts on skin flora. More cosmetics news in brief.

Perfect Corp., a firm providing augmented reality (AR) and artificial intelligence (AI) software-as-a-service solutions to beauty and fashion companies, will combine with Hong Kong-based special purpose acquisition company Provident Acquisition Corp. and list on the Nasdaq Stock Exchange, trading under the symbol, “PERF,” the New York-based company announced on 3 March. The move is intended to accelerate Perfect’s global expansion, extend its industry coverage to sectors outside beaty and fashion, and further develop its AR and AI solutions, including product try-on, facial diagnostics and digital consultation solutions, the company says, targeting the 2022 third quarter for the transaction’s completion.

Founded in 2015, Perfect has 44 patents and other pending-patent applications, and its solutions are utilized by 95% of the world’s top 20 global beauty groups and more than 400 beauty brands in more than 80 countries. “We empower brands large and small to provide their customers with an enjoyable, convenient and personalized omnichannel shopping experience through innovative technologies,” Perfect founder and CEO Alice Chang says

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

Supplementation Unlikely To Help With Hereditary Hair Loss, Says German Agency

 
• By David Ridley

Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”

Melatonin And Buccal Acyclovir On German Switch Committee Agenda

 
• By David Ridley

An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.

Plenty For Industry To Do As EU Wastewater Directive Faces Legal Challenges

 
• By David Ridley

Engaging with EU member state legislators, stressing the impact of national EPR systems on the accessibility, availability, and affordability of medicines, reformulating products to reduce their financial contribution, and lobbying for expanding the scope of EPR schemes to include other polluting industries are all ways that the European consumer health industry can try and influence the way that the revised Urban Wastewater Treatment Directive is transposed into national legislation, law firm Mason Hayes & Curran explains.

French Agency Proposes Effective EU Ban On CBD In Foods And Cosmetics

 
• By David Ridley

France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.

More from HBW Insight

US FDA Supplement Office Chief Eyes ‘Movement’ This Year On NDI Notifications Final Guidance

 
• By Malcolm Spicer

“We've made some progress and really hope to see some movement as we move forward this year,” says FDA Office of Dietary Supplement Programs director Cara Welch.

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By Tom Gallen

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Over The Counter: Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer

 
• By David Ridley

In part 2 of HBW Insight's interview, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, explains how to approach real world evidence so that regulators recognize its validity, in supporting Rx-to-OTC switch applications, for example.